Lactose
Drug profile
Also known as: (+)-Lactose, aletobiose, anhydrous lactose, dilactose, lactobiose, respitose
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Lactose is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including LGALS9, LGALS8 and LGALS3. Recorded indications include Lactose intolerance.
- Molecular targets: LGALS9, LGALS8 and LGALS3 (3 listed in DrugCentral).
- Indications: Lactose intolerance.
- Molecular formula: C12H22O11; molecular weight 342.30 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Lactose intolerance
Off-label uses (1)
- Indigestion
Mechanism & targets
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Galectin-9 | LGALS9 | unknown | Kd 4.64 |
| Galectin-8 | LGALS8 | unknown | Kd 4.21 |
| Galectin-3 | LGALS3 | unknown | Kd 4.03 |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Allergic reaction to excipient | 160.0 |
| Drug hypersensitivity | 135.9 |
| Iodine allergy | 59.8 |
| Allergy to metals | 58.7 |
| Eye oedema | 49.7 |
| Rubber sensitivity | 49.5 |
| Angioedema | 44.2 |
| Reaction to excipient | 39.3 |
| Swelling face | 32.1 |
| Urticaria | 30.3 |
Chemical structure
| Molecular formula | C12H22O11 |
|---|---|
| Molecular weight | 342.30 g/mol |
| CAS number | — |
| InChIKey | GUBGYTABKSRVRQ-XLOQQCSPSA-N |
| PubChem CID | 6134 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Lactose used for?
DrugCentral lists the following indications for Lactose: Lactose intolerance.
How does Lactose work?
Its molecular targets in DrugCentral include LGALS9, LGALS8 and LGALS3.
What is the chemical formula of Lactose?
Lactose has the molecular formula C12H22O11 and a molecular weight of 342.30 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1535 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL5314358 — compound record and bioactivity
- PubChem CID 6134 — chemical identifiers
- DrugBank DB04465 — drug record
- FDA UNII 3SY5LH9PMK — substance identity
- UniProt O00182 (LGALS9) — target protein
- UniProt O00214 (LGALS8) — target protein
- UniProt P17931 (LGALS3) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.